期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

肝细胞凋亡在多囊肝病发病中的临床意义 被引量：3

原文传递
导出
摘要 本研究旨在观察肝细胞凋亡及细胞凋亡相关蛋白在多囊肝病（PCLD）发病机制中的作用及其临床意义。
作者 米富海 支永发
机构地区 青海红十字医院急诊外科
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2009年第10期1384-1384,共1页 Chinese Journal of Experimental Surgery
关键词 肝细胞凋亡 临床意义 多囊肝病 发病机制 细胞凋亡相关蛋白
分类号 R575 [医药卫生—消化系统] R657.3 [医药卫生—外科学]
  • 相关文献

参考文献3

二级参考文献15

  • 1申洪.免疫组织化学染色定量方法研究（Ⅲ）[J].中国组织化学与细胞化学杂志,1995,4(1):89-92. 被引量：398
  • 2张辉,张有成,王杉,叶颖江.选择性环氧化酶-2抑制剂抗结肠癌作用途径研究[J].中华实验外科杂志,2004,21(7):798-800. 被引量：10
  • 3Hara I, Miyake H, Takechi Y, et al. Clinical outcome of conservative therapy for stage T1 ,grade3 transitional cell carcinoma of the bladder.Int J Urol,2003,10 : 19-24.
  • 4Huang YL, Chou CK. bcl-2 blocks apoptotic signal of transforming growth factor-beta in human hepatoma cells. J Biomed Sci, 1998, 5:185-191.
  • 5谭晓华，张亚历,姜泊．凋亡细胞形态学特征的检测方法．姜泊．细胞凋亡基础与临床(第1版)．北京：人民军医出版社,1999．255—265．
  • 6Kim FIJ ,So Y ,Jang JH, et al. Differential cell death induced by salsolinol with and without copper: possible role of reactive oxygen species.Mol Pharmacol, 2001,60 : 440-449.
  • 7Zhong LT, Sarafian T, Kane DJ, et al. bcl-2 inhibits death of central neural cells induced by multiple agents. Proc Natl Acad Sci USA,1993,90:4533-4537.
  • 8Blum D, Torch S, Nissou MF, et al. 6-Hydroxydopamine-induced nuclear factor-kappaB activation in PC12 cells. Biochem Pharmacol,2001,62:473-481.
  • 9McKnight J J, Gray SB, O' Kane HF, et al. Apoptosis and chemotherapy for bladder cancer. J Urol,2005,173:683-690.
  • 10Hockenbery DM,Oltvai ZN,Yin X, et al. bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell, 1993,75:241-251.

共引文献22

同被引文献19

  • 1Salvatore Gruttadauria,Fabrizio di Francesco,Bruno Gridelli.Liver transplantation for polycystic liver and massive hepatomegaly[J].World Journal of Gastroenterology,2010,16(11):1425-1426. 被引量：5
  • 2Deha Erdogan,Otto M van Delden,Erik AJ Rauws,Olivier RC Busch,Johan S Lameris,Dirk J Gouma,Thomas M van Gulik.Results of percutaneous sclerotherapy and surgical treatment in patients with symptomatic simple liver cysts and polycystic liver disease[J].World Journal of Gastroenterology,2007,13(22):3095-3100. 被引量：16
  • 3Tarter B, Willingham DL, Hewitt WR, et al. Polycystic liver disease and liver transplantation: single-institution experience. Transplant Proc, 2009, 41: 3769-3771.
  • 4Ubara Y. New therapeutic option for autosomal dominant polycystic kidney disease patients with enlarged kidney and liver. Ther Apher Dial, 2006, 10: 333-341.
  • 5Takei R, Ubara Y, Hoshino J, et al. Percutaneous transcatheter hepatic artery embolization for liver cysts in autosomal dominant polycystic kidney disease. Am I Kidney Dis, 2007, 49:744-752.
  • 6Park HC, Kim CW, Ro H, et al. Transcatheter arterial embolization therapy for a massive polycystic liver in autosomal dominant polycystic kidney disease patients. J Korean Med Sci, 2009, 24: 57-61.
  • 7Sakuhara Y, Kato F, Abo D, et al. Transcatheter arterial embolization with absolute ethanol injection for enlarged polycystic kidneys after failed metallic coil embolization. J Vasc Interv Radiol, 2008, 19(2 Pt 1): 267-271.
  • 8Van Keimpema L,Drenth JP. Polycystic liver disease:a critical appraisal of hepatic resection,cyst fenestration,and liver transplantation[J].{H}ANNALS OF SURGERY,2011.419-420.
  • 9Arnold HL,Harrison SA. New advances in evaluation and management of patients with polycystic liver disease[J].{H}American Journal of Gastroenterology,2005.2569-2582.
  • 10Ubara Y,Takei R,Hoshino J. Intravascular embolization therapy in a patient with an enlarged polycystic liver[J].{H}American Journal of Kidney Disease,2004.733-738.

引证文献3

二级引证文献10

中华实验外科杂志
2009年 第10期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部